Lumbar Disc Hernia, Erector Spinae Plane Block, Ilesi

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorDiskapi Teaching and Research Hospital

About this trial

The study is designed as an observational study. Patients who have been treated and completed treatment for lumbar discopathy in our clinic will be followed. Patients will not be divided into groups beforehand, and this will not cause changes to the treatment plan. Patients who have undergone fluoroscopy-guided lumbar interlaminar epidural steroid injection (LESI) and ultrasound-guided lumbar erector spinae plane block (LESP), routinely performed in our clinic for the treatment of back and leg pain due to lumbar disc herniation, will be compared to the effectiveness of these methods on pain at baseline before the procedure and at 2, 6, and 12 weeks afterward using the Visual Analogue Scale for Pain Relief (VAS) and Oswestry Disability Index (ODI). The baseline values will be recorded from the patient files and by request before the start of follow-up.

Eligibility criteria

Qualifiers

Patients with chronic low back pain caused by L4-L5 and L5-S1 lumbar disc herniation accompanied by radicular pain, including those diagnosed by MRI, will be included.

Patients with low back pain above VAS 5 for more than 6 weeks will be included.

Failure of pain treatment with conservative methods such as analgesics and physical therapy

Disqualifiers

Patients who have previously undergone lumbar surgery,

Patients with spinal deformity and stenosis,

Patients with uncontrolled diabetes

Patients allergic to the drugs to be used will not be included in the study.

Trial design

Treatments tested in this trial

  • us-guided espb
  • fl-guided Ilesi

Treatment groups

80 Participants
are divided into 2 treatment groups